Cannabis Report
Home > Boards > US OTC > Biotechs > CYTODYN INC (CYDY)

If the FDA examined the data and is

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
BlueHorseshoe13 Member Profile
 
Followed By 6
Posts 110
Boards Moderated 1
Alias Born 05/10/16
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 7/12/2018 4:32:55 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/27/2018 9:02:31 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/22/2018 5:02:40 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/15/2018 7:49:45 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/15/2018 7:44:52 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2018 6:04:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2018 6:03:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2018 5:59:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2018 5:59:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2018 5:57:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2018 5:56:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2018 5:56:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2018 5:55:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2018 5:54:17 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/7/2018 4:24:25 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/22/2018 8:16:33 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/22/2018 7:46:52 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/22/2018 7:45:17 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 5/8/2018 4:06:32 PM
Proxy Soliciting Materials (revised) (prer14a) Edgar (US Regulatory) - 5/4/2018 10:54:38 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 4/26/2018 5:09:17 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/11/2018 6:09:06 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 4/9/2018 4:34:49 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 3/26/2018 5:27:48 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/26/2018 5:25:36 PM
BlueHorseshoe13   Friday, 11/10/17 10:04:26 AM
Re: Inoviorulez post# 18087
Post # of 25678 
If the FDA examined the data and is looking for statistical relevance, it by definition means they are attempting to prove/dis-prove an anomaly. Meaning the early data is outside of the bell curve for established treatments. From that one could infer that the early results were not only good, but game changing. If the additional patients confirm this, well, the rest will be history. Best of luck to you all, and most importantly to all of those patients in need who may very soon have a life changing option.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist